Skip to main content
. 2022 Jan 18;53(2):363–371. doi: 10.1007/s11239-022-02631-7

Table 2.

Medications

DM No DM (n = 73) p value
Metformin (n = 34) No metformin (n = 41) Metformin vs. no metformin Metformin vs. no DM No metformin vs. No DM
Antiviral medications, n (%)
 Remdesivir 10 (29) 12 (29) 21 (29) 1.00 1.00 1.00
 Hydroxychloroquine 2 (6) 4 (10) 5 (7) 0.53 0.85 0.57
 Convalescent plasma 8 (24) 16 (39) 21 (29) 0.17 0.59 0.28
Antithrombotic medications, n (%)
 None 3 (9) 4 (10) 7 (10) 0.88 0.87 1.00
 Enoxaparin prophylaxis 18 (53) 13 (32) 40 (55) 0.07 0.85 0.02
 Heparin prophylaxis 7 (21) 9 (22) 13 (18) 0.92 0.71 0.61
 Therapeutic anticoagulation 4 (12) 11 (27) 9 (12) 0.11 1.00 0.04
 Direct oral anticoagulant 2 (6) 4 (10) 4 (5) 0.53 0.83 0.31
Aspirin 14 (41) 14 (34) 16 (22) 0.54 0.04 0.16
Antibiotic medications, n (%)
 Ceftriaxone 15 (44) 16 (39) 37 (51) 0.66 0.50 0.22
 Azithromycin 16 (47) 12 (29) 36 (49) 0.11 0.85 0.04
 Vancomycin 6 (18) 6 (15) 7 (10) 0.73 0.25 0.43
Steroids 25 (74) 30 (73) 48 (66) 0.92 0.41 0.44
Statins 13 (38) 21 (51) 18 (25) 0.26 0.17 0.005
Proton pump inhibitors/H2 blockers 10 (29) 22 (54) 24 (33) 0.03 0.68 0.03

Therapeutic anticoagulation = full dose heparin administration

Direct oral anticoagulant = apixaban